Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single molecule protein analysis platform, today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024.
西雅图，2024年4月11日（GLOBE NEWSWIRE）——开创单分子蛋白分析平台的公司鹦鹉螺生物技术有限公司（纳斯达克股票代码：NAUT；或 “Nautilus”）今天宣布，将在2024年4月30日星期二开市前公布2024年第一季度的财务业绩。
The company's management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the "Investors" section of the company website at: www.nautilus.bio.
该公司的管理层将从太平洋时间上午 5:30 /美国东部时间上午 8:30 开始网络直播相应的电话会议，讨论其业绩、业务发展和前景。网络直播的直播音频将在公司网站的 “投资者” 部分提供，网址为： www.nautilus.bio。
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus' mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
关于鹦鹉螺生物技术有限公司
Nautilus是一家处于开发阶段的生命科学公司，其公司总部位于华盛顿州西雅图，研发总部位于加利福尼亚州的圣卡洛斯，致力于开发一种用于量化和解锁蛋白质组复杂性的平台技术。Nautilus的使命是通过普及蛋白质组并实现人类健康和医学领域的根本进步来改变蛋白质组学领域。要了解有关 Nautilus 的更多信息，请访问 www.nautilus.bio。
Media Contact
press@nautilus.bio
媒体联系人
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
投资者联系人
investorrelations@nautilus.bio